Genscript Biotech Corporation (GNNSF)
USD 1.25
(0.0%)
USD 1.25
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 839.52 Million | 625.69 Million | 511.06 Million | 390.84 Million | 273.35 Million | 231.01 Million |
| Cost of Revenue | 429.97 Million | 321.61 Million | 207.57 Million | 134.95 Million | 93.06 Million | 72.47 Million |
| Gross Profit | 409.55 Million | 304.08 Million | 303.48 Million | 255.89 Million | 180.29 Million | 158.53 Million |
| Operating Expenses | 825.34 Million | 731.83 Million | 651.73 Million | 447.88 Million | 303.67 Million | 149.83 Million |
| Selling, General and Administrative Expenses | 392.51 Million | 350.81 Million | 302.47 Million | 197.68 Million | 125.61 Million | 79.35 Million |
| Research and Development Expenses | 432.82 Million | 390.09 Million | 358.4 Million | 263.4 Million | 186.02 Million | 74.07 Million |
| Other Expenses | - | -21.47 Million | -151.58 Million | -14.33 Million | -384 Thousand | -36 Thousand |
| Cost and Expenses | 1.25 Billion | 1.05 Billion | 859.3 Million | 582.83 Million | 396.73 Million | 222.3 Million |
| Operating Income | -415.79 Million | -436.03 Million | -497.04 Million | -206.63 Million | -112.09 Million | 22.43 Million |
| Interest Expense | 27.51 Million | 13.26 Million | 2.37 Million | 1.41 Million | 781 Thousand | 52 Thousand |
| Income Tax Expense | 4.14 Million | -3.71 Million | 4.57 Million | -477 Thousand | 3.82 Million | 1.94 Million |
| Earnings before Tax | -350.97 Million | -431.69 Million | -496.37 Million | -281.9 Million | -113.69 Million | 22.7 Million |
| Net Income | -95.47 Million | -226.85 Million | -347.86 Million | -204.94 Million | -96.91 Million | 21.21 Million |
| Earnings Per Share Basic | -0.05 | -0.11 | -0.17 | -0.11 | -0.05 | 0.01 |
| Earnings Per Share Diluted | -0.05 | -0.11 | -0.17 | -0.11 | -0.05 | 0.01 |
| Weighted Average Shares Outstanding | 2.1 Billion | 2.09 Billion | 2.03 Billion | 1.9 Billion | 1.85 Billion | 1.79 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.1 Billion | 2.09 Billion | 2.03 Billion | 1.9 Billion | 1.85 Billion | 1.83 Billion |
| Gross Margin | 0.49 | 0.49 | 0.59 | 0.65 | 0.66 | 0.69 |
| EBIT Margin | -0.30 | -0.59 | -0.88 | -0.44 | -0.33 | 0.15 |
| Profit Margin | -0.11 | -0.36 | -0.68 | -0.52 | -0.35 | 0.09 |
| EBITDA | -248.71 Million | -355.07 Million | -465.78 Million | -243.04 Million | -92.47 Million | 35.36 Million |
| Earnings Before Tax Margin | -0.50 | -0.70 | -0.97 | -0.53 | -0.41 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 280.68 Million | 280.68 Million | 841.49 Million | 448.71 Million | 224.1 Million | 391.3 Million |
| Cost of Revenue | 127.19 Million | 127.19 Million | 430.98 Million | 213.94 Million | 106.85 Million | 216.25 Million |
| Gross Profit | 153.49 Million | 153.49 Million | 410.51 Million | 234.76 Million | 117.25 Million | 175.04 Million |
| Operating Expenses | 228.87 Million | 228.87 Million | 801.53 Million | 407.08 Million | 186.52 Million | 393.01 Million |
| Selling, General and Administrative Expenses | 110.68 Million | 110.68 Million | - | 181.34 Million | 101.11 Million | 185.68 Million |
| Research and Development Expenses | 118.19 Million | 118.19 Million | - | 225.74 Million | 112.74 Million | 207.32 Million |
| Other Expenses | -283.79 Million | - | -27.03 Million | - | - | - |
| Cost and Expenses | 356.07 Million | 356.07 Million | 1.23 Billion | 621.03 Million | 293.38 Million | 609.27 Million |
| Operating Income | -75.38 Million | -75.38 Million | -391.01 Million | -172.32 Million | -96.61 Million | -217.96 Million |
| Interest Expense | 14.48 Million | - | 27.51 Million | 15.07 Million | - | 12.46 Million |
| Income Tax Expense | 5.02 Million | 5.02 Million | 4.15 Million | 3.04 Million | 1.51 Million | 1.1 Million |
| Earnings before Tax | -102.79 Million | -102.79 Million | -350.41 Million | -105.28 Million | -53.16 Million | -244.41 Million |
| Net Income | -87.55 Million | -87.55 Million | -95.7 Million | -1.89 Million | -948 Thousand | -93.57 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | - | -0.00 | -0.00 | -0.04 |
| Earnings Per Share Diluted | -0.04 | -0.04 | - | -0.00 | -0.00 | -0.04 |
| Weighted Average Shares Outstanding | 2.11 Billion | 2.11 Billion | 2.1 Billion | 2.09 Billion | 1.99 Billion | 2.1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.11 Billion | 2.11 Billion | 2.1 Billion | 2.09 Billion | 2.11 Billion | 2.1 Billion |
| Gross Margin | 0.55 | 0.55 | 0.49 | 0.52 | 0.52 | 0.45 |
| EBIT Margin | -0.21 | -0.21 | - | -0.30 | -0.37 | -0.47 |
| Profit Margin | -0.31 | -0.31 | -0.11 | -0.00 | -0.00 | -0.24 |
| EBITDA | -58.96 Million | -58.96 Million | - | -133.79 Million | -82.14 Million | -182.44 Million |
| Earnings Before Tax Margin | -0.27 | -0.27 | -0.46 | -0.38 | -0.43 | -0.56 |
POH1
HSHIF
GATO
PINFRA
RF-PB
0251